HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House, Senate Appropriations Committees More Than Match Request For FDA

This article was originally published in The Rose Sheet

Executive Summary

House and Senate appropriators made certain in their recommendations for fiscal 2008 appropriations that FDA would be given opportunity to extend the scope of its oversight, with both houses of Congress more than matching the President's request

You may also be interested in...



FDA appropriations bill passes House

The House on Aug. 2 passed its appropriations bill (H.R. 3161), which proposes $1.69 bil. in direct funding for FDA in fiscal 2008. No significant changes affecting FDA were made to the bill sent to the floor by the Agriculture Appropriations Subcommittee (1"The Rose Sheet" July 23, 2007, p. 8). The same day, Sen. Mike Enzi, R-Wyo., asked Majority Leader Harry Reid, D-N.V., to delay naming conferees for the legislation. "If we do this too early, we set ourselves up for the blame game, not for getting this key legislation done," Enzi said. The Senate has not yet passed its corresponding bill (S. 1859)...

FDA appropriations bill passes House

The House on Aug. 2 passed its appropriations bill (H.R. 3161), which proposes $1.69 bil. in direct funding for FDA in fiscal 2008. No significant changes affecting FDA were made to the bill sent to the floor by the Agriculture Appropriations Subcommittee (1"The Rose Sheet" July 23, 2007, p. 8). The same day, Sen. Mike Enzi, R-Wyo., asked Majority Leader Harry Reid, D-N.V., to delay naming conferees for the legislation. "If we do this too early, we set ourselves up for the blame game, not for getting this key legislation done," Enzi said. The Senate has not yet passed its corresponding bill (S. 1859)...

Tainted toothpaste in Connecticut

More than 700 tubes of toothpaste containing diethylene glycol (DEG) have been discovered and confiscated in Connecticut - 430 tubes of counterfeit Colgate reportedly made in South Africa and 275 tubes of Chinese-made Dentakleen and Dentakleen Junior strawberry and blueberry flavor, according to a July 9 release from the Department of Consumer Protection. The products were found primarily in discount stores in the Hartford and Bridgeport areas, the DCP says. Letters have gone out to two importer/distributors based in Danbury, Conn. and North Bergen, N.J., as well as to a number of Chinese manufacturers demanding "the number of tubes shipped to Connecticut, their lot and brand names, the number so far returned as a result of the recall, the names and addresses of any Connecticut residents who complained to the companies and other information." Colgate-Palmolive issued a statement warning consumers of counterfeit, DEG-containing Colgate products in mid-June (1"The Rose Sheet" June 18, 2007, In Brief). Earlier that month, FDA launched a recall of all dentrifice products formulated with DEG after the toxin was identified in several Chinese-made products (2"The Rose Sheet" June 11, 2007, p. 8)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014862

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel